Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers
健康志愿者暴露和停用托法替尼（一种 Janus 激酶抑制剂）后外周血白细胞表型和功能变化的可逆性
期刊:Clinical Immunology
影响因子:4.5
doi:10.1016/j.clim.2018.03.002
Kent J Weinhold, Jack F Bukowski, Todd V Brennan, Robert J Noveck, Janet S Staats, Liwen Lin, Linda Stempora, Constance Hammond, Ann Wouters, Christopher F Mojcik, John Cheng, Mark Collinge, Michael I Jesson, Anasuya Hazra, Pinaki Biswas, Shuping Lan, James D Clark, Jennifer A Hodge8
